Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/sMbQhMrCDsgTktKTuB

 
From Stanley K. Fergus and the American College of GastroenterologyNovember 13, 2009
 
 
 

Top Story


  • Recent studies point to progress in war on cancer
    The war on cancer is entering its fifth decade and researchers found 51 studies released in the past year that point to progress being made. Their report, "Clinical Cancer Advances 2009," includes trials on therapies for gastric cancer, colon cancer and biliary tract cancer. MedPage Today (free registration) (11/9) Email this Story

Guide to Healthy Living


  • Expert discusses changing face of ulcer disease
    The U.S. has seen a significant drop in Helicobacter pylori infection and H. pylori-related ulcers due in part to cleaner water, better sanitation, and improved detection and treatment, gastroenterologist Dr. Nimish Vakil told The New York Times. Vakil, who helped write the ACG guidelines for managing upper abdominal pain, said the most important cause of ulcer disease in the U.S. is from the use of nonsteroidal anti-inflammatory drugs, though immigrant populations still face high rates of peptic ulcer disease linked to H. pylori. The New York Times (11/5) Email this Story
  • GERD patient eager for Thanksgiving following surgery
    Connie Braswell of Jackson, Miss., plans to enjoy eating for the first time at Thanksgiving in five years, thanks to surgery to relieve gastroesophageal reflux disease. She had transoral incisionless fundoplication surgery in late October, which uses a EsophyX device that goes through a patient's mouth, rather than having the more traditional laparoscopic surgery. The Clarion-Ledger (Jackson, Miss.) (11/10) Email this Story

Diagnosis & Treatment


  • Vitamin E shows promise for NASH patients
    Researchers said 43% of nonalcoholic steatohepatitis patients taking vitamin E for two years met a clinical trial primary endpoint of improved liver function, decreased ballooning and stabilization of fibrosis, compared with less than 20% of patients on a placebo. NASH patients taking pioglitazone or Actos also improved but did not meet the trial's primary endpoint. MedPage Today (free registration) (11/6) Email this Story

Policy Watch


The Last Word

News and information from the American College of Gastroenterology

  • Take the itch and burn out of hemorrhoids -- Tips to reduce pain and discomfort
    Are you tired of the itch and burn of hemorrhoids? While it's a fairly common condition, many patients may be too embarrassed to talk to their doctor about it. The ACG has tips to reduce the pain and discomfort of hemorrhoids. Email this Story

SmartQuote

Always forgive your enemies; nothing annoys them so much."
--Oscar Wilde,
Irish writer


 

"I have lost friends along the way.... But I do believe things happen for a reason. Maybe I was diagnosed with this to be a more compassionate and patient person (I definitely am more tolerant)." -- posting on Crohn's & Colitis Foundation of America

 
 
Subscriber Tools
     
Designate Doctor |  Print friendly format

Contact Your Doctor
Stanley K. Fergus
Gastroenterolgy Associates of West Tennessee
1400 Kings Boulevard
Memphis, TN 38105

Phone: (901) 555-1234
 
Contact ACG
American College of Gastroenterology
P.O. Box 342260
Bethesda, MD 20827-2260

Contact SmartBrief
Advertise
Sales Associate:
Eric Yeager
(202) 737-5500 ext. 255
Contact
SmartBrief, Inc.®
1100 H ST NW, Suite 1000
Washington, DC 20005
 
 
  The presence of any advertisement in this newsletter does not constitute endorsement of the associated service, product, or company by the American College of Gastroenterology, SmartBrief, or any participating physicians.

The information contained in Digestive Health SmartBrief is not intended to be medical advice. Consult your physician before making any decisions regarding your health care.
 
 
© 1999-2009 SmartBrief, Inc.® Legal and Privacy Information